Corneal collagen crosslinking in Bullous Keratopathy and Other causes of corneal oedema
Hanan Ismail Mohamed Rashdan;
Abstract
corneal stroma composed mainly of type I collagen fibrils with types III, V, and VI also found, these are woven into equidistant lamellae. By inducing cross links between neighboring collagen fibers the corneal rigidity improved.
Riboflavin and UV-A cross-linking of corneal collagen is a relatively new method that attempts to increase the biomechanical stability of the cornea by inducing additional cross-links between or within collagen fibers, (increase the formation of intra and interfibrillar covalent bonds by photosensitized oxidation).Riboflavin is used as a photomediator when exposed to UV-A light.
This method results in an increase in corneal tensile strength, with no medium term adverse effects on its normal architecture. Clinically, treated patients display improvement in both visual acuity and keratometric readings.
Since first introduction of Collagen Cross-linking (CXL) into ophthalmology 5 years ago, the use of riboflavin UVA collagen cross-linking has been gaining popularity in the treatment of progressive keratoconus, and current estimates suggest that 1000 procedures are performed each month worldwide
With this growing popularity, other novel applications are being proposed for the use of riboflavin UVA cross-linking in ophthalmology, such as the treatment of postoperative LASIK ectasia, strengthening of recalcitrant corneal ulcerations, halting of progressive axial myopia.
This treatment has also been used to treat infectious corneal ulcers with apparently favorable results and also in cases of bullous keratopathy.
CXL has also been used in combination with other treatments, such as intracorneal ring segment implantation and limited topography-guided photoablation, with some success.
Corneal CXL mediated by riboflavin and UVA appears to be a safe and efficacious procedure in halting the progression of keratoconus and iatrogenic ectasia. CXL reduces the corneal curvature, spherical equivalent refraction and refractive cylinder in eyes with corneal instability and progressive irregular astigmatism due to keratoconus and ectasia. The CXL technique is promising in treating corneal melting conditions or infectious keratitis because cross-linking would strengthen a collagenolytic cornea while UVA irradiation eliminates the infectious agent.
Bullous keratopathy (BK) is a visually-disabling corneal disorder and a state of abnormal corneal epithelial hydration caused by endothelial cell dysfunction. Without sufficient endothelial function, fluid accumulates in the extracellular spaces between collagen fibers and lamellae
Riboflavin and UV-A cross-linking of corneal collagen is a relatively new method that attempts to increase the biomechanical stability of the cornea by inducing additional cross-links between or within collagen fibers, (increase the formation of intra and interfibrillar covalent bonds by photosensitized oxidation).Riboflavin is used as a photomediator when exposed to UV-A light.
This method results in an increase in corneal tensile strength, with no medium term adverse effects on its normal architecture. Clinically, treated patients display improvement in both visual acuity and keratometric readings.
Since first introduction of Collagen Cross-linking (CXL) into ophthalmology 5 years ago, the use of riboflavin UVA collagen cross-linking has been gaining popularity in the treatment of progressive keratoconus, and current estimates suggest that 1000 procedures are performed each month worldwide
With this growing popularity, other novel applications are being proposed for the use of riboflavin UVA cross-linking in ophthalmology, such as the treatment of postoperative LASIK ectasia, strengthening of recalcitrant corneal ulcerations, halting of progressive axial myopia.
This treatment has also been used to treat infectious corneal ulcers with apparently favorable results and also in cases of bullous keratopathy.
CXL has also been used in combination with other treatments, such as intracorneal ring segment implantation and limited topography-guided photoablation, with some success.
Corneal CXL mediated by riboflavin and UVA appears to be a safe and efficacious procedure in halting the progression of keratoconus and iatrogenic ectasia. CXL reduces the corneal curvature, spherical equivalent refraction and refractive cylinder in eyes with corneal instability and progressive irregular astigmatism due to keratoconus and ectasia. The CXL technique is promising in treating corneal melting conditions or infectious keratitis because cross-linking would strengthen a collagenolytic cornea while UVA irradiation eliminates the infectious agent.
Bullous keratopathy (BK) is a visually-disabling corneal disorder and a state of abnormal corneal epithelial hydration caused by endothelial cell dysfunction. Without sufficient endothelial function, fluid accumulates in the extracellular spaces between collagen fibers and lamellae
Other data
| Title | Corneal collagen crosslinking in Bullous Keratopathy and Other causes of corneal oedema | Other Titles | استخدام تقنية تثبيت القرنية فى اعتلال القرنية الفقاعى والحالات الأخرى لتورم القرنية | Authors | Hanan Ismail Mohamed Rashdan | Issue Date | 2015 |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| G10903.pdf | 433.35 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.